Microneedle Arrays Research Articles

Microneedle Arrays: Advancements, Applications and Future Prospects in Pharmaceutical Delivery

Microneedle arrays have emerged as a cutting-edge technology revolutionizing the field of pharmaceutical delivery. These micron-sized needles offer a minimally invasive and painless approach to administer drugs, vaccines, and various therapeutic agents through the skin, bypassing traditional routes of administration. This review article comprehensively explores the advancements, applications, and future prospects of microneedle arrays in pharmaceutical delivery. This review delves into the different types of microneedle arrays, including solid, hollow, dissolving, and coated microneedles, highlighting their unique properties and fabrication techniques. The discussion encompasses recent breakthroughs in microneedle design, such as biodegradable materials, smart responsive systems, and personalized arrays tailored to specific patient needs. Furthermore, this review addresses the challenges and safety considerations associated with microneedle usage, such as skin irritation and regulatory aspects. It analyzes ongoing research efforts aimed at optimizing design, functionality, and scalability for large-scale manufacturing. The future prospects of microneedle arrays in pharmaceutical delivery qwew also discussed. Anticipated advancements in the field, including personalized medicine, combination therapy, and disease monitoring through biosensing, offer promising avenues for transformative healthcare solutions. In conclusion, microneedle arrays represent a paradigm shift in pharmaceutical delivery, offering numerous advantages over traditional methods. As research and development continue, these micro-sized devices hold the potential to revolutionize the landscape of drug administration, leading to safer, more effective, and patient-centric healthcare practices.

Long‐Lasting Simultaneous Epidermal and Dermal Microneedle‐Enabled Drug Delivery

AbstractDifferent skin diseases, such as cancers, inflammatory conditions, and bacterial infections, manifest at distinct skin depths. Microneedle arrays, recognized for their painless and minimally invasive drug administration, can be customized to penetrate these layers simultaneously. Here, the design of the microneedles (MNs) in nonlinear ways with diverse needle heights on the array enabling concurrent drug delivery to various skin layers is engineered. Additionally, varying the base diameter of the needles in the array facilitates prolonged or intermittent drug release, depending on the biodegradation kinetics of these needles. MNs, microfabricated with a biocompatible and biodegradable polymer, are validated by skin administration. The nonlinear design of the MNs on the array introduces a novel perspective on addressing skin diseases at varying depths of the skin.

Development of an osmosis-assisted hollow microneedle array integrated with dual-functional electrochemical sensor for urea and pH monitoring in interstitial fluid

In healthcare, accurate detection of biomarkers is paramount for disease diagnosis, prevention, and personal health surveillance. This study focused on developing and validating a MgCl2 deposited hollow microneedle array integrated with a dual-functional sensor system, which was used for osmosis-assisted boosted interstitial fluid extraction, the simultaneous and continuous monitoring of urea and pH in interstitial fluid. The urea sensor component was fabricated by electro-depositing prussian blue onto a carbon electrode, followed by applying a molecularly imprinted polymer layer, ensuring high specificity and sensitivity. The pH sensor was constructed through electropolymerization of polyaniline, exhibiting a linear response across a wide pH range. When tested in artificial skin matrix, the system demonstrated excellent in vitro electrochemical sensing performance with high linearity and repeatability. At the same time, the practical in vivo sensing performance of the system was verified in Sprague-Dawley (SD) rats. The development of the system underscores its potential as a valuable tool for continuous health monitoring.

Customized Corneal Cross-Linking with Microneedle-Mediated Riboflavin Delivery for Keratoconus Treatment.

In this study, a novel customized corneal cross-linking (CXL) treatment is explored that utilizes microneedles (MNs) for targeted riboflavin (RF) administration prior to the CXL procedure. Unlike the conventional "one-size-fits-all" approach, this protocol offers an option for more precise and efficacious treatment. To simulate a customized corneal crosslinking technique, four distinct microneedle (MN) molds designs, including circular, semi-circular, annular and butterfly shaped, are crafted for loading an optimized RF-hyaluronic acid solution and for the subsequent fabrication of MN arrays with varying morphologies. These MNs can gently puncture the corneal epithelium while preserving the integrity of the underlying stromal layer. Following the application of these microneedles, RF solution is replenished to enhance the RF content within the stroma through the punctures created by the MNs, resulting in exceptional customized corneal cross-linking effects that are comparable to the conventional epi-off CXL protocol. Additionally, it flattened the corneal curvature within the treated zone and facilitated rapid postoperative recovery of corneal tissue. These findings suggest that the integration of customized microneedle RF delivery with corneal crosslinking technology represents a potential novel treatment modality, holding promise for the tailored treatment of corneal pathologies, and offering a more precise and efficient alternative to traditional methods.

Photothermal-enhanced detoxification metal-organic framework microneedle array for 2-chloroethyl ethyl sulfide-poisoned wound healing

Sulfur mustard (2,2′-dichloroethylsulfide; SM) is a bifunctional alkylating agent that can easily penetrate skin and cause persistent pain and damage. Effective biological dressings are required to treat wounds caused or poisoned by SM. Though the use of SM is regulated under the Chemical Weapons Convention, it is still a threat during wars and terrorist attacks. Herein, we present a photothermal-enhanced detoxification microneedles array (MNA) encapsulated with ZnIn2S4@UiO-66-NH2 (ZnInS/UIO) catalysts for the treatment of 2-chloroethyl ethyl sulfide (CEES, SM analog)-poisoned wounds under simulated sunlight (SSL) irradiation. Due to the excellent photothermal detoxification capability possessed by ZnInS/UIO, the conversion rate of CEES can be significantly increased under SSL exposure. When encased in a polyvinyl alcohol (PVA) MNA and piercing into the skin, ZnInS/UIO catalysts can be released quickly from MNA for detoxification. After applying the resultant ZnInS/UIO-MNA to the CEES-poisoned wound bed, acceleration of the wound healing process and a reduced inflammatory response can be confirmed. In conclusion, ZnInS/UIO-MNA has encouraging potential as a first-aid dressing for CEES-poisoned wound healing in battlefields and injuries related to acts of terrorism.

Flexible plasmonic microneedle array-based SERS sensor for pH monitoring of skin interstitial fluid

Interstitial fluid (ISF) is a prevalent accessible and information-rich biofluid, and monitoring pH level of interstitial fluid plays a crucial role in the physiological health assessment. However, facile extraction of ISF and sensitive detection of pH is still a great challenge. Herein, a flexible plasmonic microneedle array (PMNA)-based SERS sensor was developed for facile and sensitive pH monitoring of skin ISF. The flexible microneedle arrays were fabricated by norland optical adhesive 65 (NOA65), and coated with pH-sensitive 4-Mercaptobenzoic acid (4-MBA)-labeled silver nanoparticles (Ag NPs) by electrostatic assembly. The proposed flexible PMNA-based SERS sensor has a good linear response in the pH range of 5 to 9 which covers the normal pH level in skin interstitial fluid. The ISF extracted from porcine skin was chosen as the test model, and the pH levels detected by the PMNA-based SERS sensors were well consistent with the theoretical results. Besides, the proposed flexible SERS sensors show good mechanical robustness, sensing stability, and biocompatibility before and after skin insertion, which can be a potential analytical tool for practical detection of pH levels in ISF and provide technical support for SERS-based wearable biosensing.

3D-Printed Latticed Microneedle Array Patches for Tunable and Versatile Intradermal Delivery.

Using high-resolution 3D printing, a novel class of microneedle array patches (MAPs) is introduced, called latticed MAPs (L-MAPs). Unlike most MAPs which are composed of either solid structures or hollow needles, L-MAPs incorporate tapered struts that form hollow cells capable of trapping liquid droplets. The latticestructures can also be coated with traditional viscous coating formulations, enabling both liquid- and solid-state cargo delivery, on a single patch. Here, a library of 43 L-MAP designs is generated and in-silico modeling is used to down-select optimal geometries for further characterization. Compared to traditionally molded and solid-coated MAPs, L-MAPs can load more cargo with fewer needles per patch, enhancing cargo loading and drug delivery capabilities. Further, L-MAP cargo release kinetics into the skin can be tuned based on formulation and needle geometry. In this work, the utility of L-MAPs as a platform is demonstrated for the delivery of small molecules, mRNA lipid nanoparticles, and solid-state ovalbumin protein. In addition, the production of programmable L-MAPs is demonstrated with tunablecargo release profiles, enabled by combining needle geometries on a single patch.

Effect of Triton X-100 surfactant and agitation on tetramethylammonium hydroxide wet etching for microneedle fabrication

Solid silicon (Si) microneedles have many applications such as skin pretreatment to form micrometer-sized holes in the skin surface in transdermal drug delivery systems. Wet etching based on tetramethylammonium hydroxide (TMAH) is an efficient method to fabricate solid microneedles. However, it is challenging to increase the density of microneedle arrays due to the faster lateral etching than the vertical etching that requires a large initial mask size. In this work, we used wet etching based on TMAH to fabricate solid Si microneedles. One kind of nonionic surfactant, Triton X-100, was introduced into the TMAH solution to suppress the lateral etching. When Triton X-100 was added into TMAH for a given etching condition, the maximum height (attained right before the mask fell off) of microneedles could reach ∼230 μm for 600 μm square-shaped mask size and 700 μm array period, compared to microneedles of maximum 152 μm height for the same mask size and period without surfactant addition. Correspondingly, when the target heights of microneedles were the same as ∼230 μm, denser (down to 700 μm period, 600 μm mask size) microneedle arrays were achieved with the help of Triton X-100, in comparison to arrays down to 900 μm period (800 μm mask size) without surfactant addition. Furthermore, agitation by a magnetic stirring bar is important for the fabrication of dense solid Si microneedle arrays based on TMAH. The microneedle structures were rhombic pyramid in shape with Triton X-100 and agitation. But microneedle structures obtained with Triton X-100 yet without agitation were octagonal pyramid in shape with a much less steep side surface.

Delivery of luminescent particles to plants for information encoding and storage

In the era of smart agriculture, the precise labeling and recording of growth information in plants pose challenges for modern agricultural production. This study introduces strontium aluminate particles coated with H3PO4 as luminescent labels capable of spatial embedding within plants for information encoding and storage during growth. The encapsulation with H3PO4 imparts stability and enhanced luminescence to SrAl2O4:Eu2+,Dy3+ (SAO). Using SAO@H3PO4 as a low-damage luminescent label, we implement its delivery into plants through microneedles (MNs) patches. The embedded SAO@H3PO4 within plants exhibits sustained and unaltered high signal-to-noise afterglow emission, with luminous intensity remaining at approximately 78% of the original for 27 days. To cater to diverse information recording needs, MNs of various geometric shapes are designed for loading SAO@H3PO4, and the luminescent signals in different shapes can be accurately identified through a designed program, the corresponding information can be conveniently viewed on a computer. Additionally, inspired by binary information concepts, MNs patches with specific arrangements of luminescent and non-luminescent points are created, resulting in varied luminescent MNs arrays on leaves. An advanced camera system with a tailored program accurately identifies and maps the labels to the corresponding recorded information. These findings showcase the potential of low-damage luminescent labels within plants, paving the way for convenient and widespread storage of plant growth information.

Finite Element Analysis of Skin Deformation and Puncture for Microneedle Array Design.

The mechanics of microneedle insertion have thus far been studied in a limited manner. Previous work has focused on buckling and failure of microneedle devices, while providing little insight into skin deformation, puncture, and the final positioning of needle tips under full microneedle arrays. The current study aims to develop a numerical approach capable of evaluating deformation and puncture conditions for full microneedle array designs. The analysis included a series of finite element submodels used to calibrate the microneedle-epidermal interface for failure properties using traction-separation laws. The single needle model is validated using experimental data and imaging, including results from a customized nanoindentation procedure to measure loads and displacements during microneedle insertion. Upon validation, full microneedle arrays are implemented in a 3 D finite element model and a design framework is developed, allowing evaluation of different design variables (i.e. needle shape, material, spacing) with respect to outputs relevant to successful microneedle performance. Results from the model include skin deformation, force to puncture, penetration depth, and the punctured state at each microneedle tip. In addition to microneedle parameters, patient parameters such as subcutaneous tissue thickness are included to evaluate the sensitivity of different microneedle designs to expected patient and anatomical region variability.

Fully integrated microneedle biosensor array for wearable multiplexed fitness biomarkers monitoring

Fitness monitoring has become increasingly important in modern lifestyles; the current fitness monitoring always relies on physical sensors, making it challenging to detect pertinent issues at a deeper level when exercising. Here, we report a fully integrated wearable microneedle sensor that simultaneously measures fitness related biomarkers (e.g., glucose, lactate, and alcohol) during physical exercise. Such a sensor integrates a biocompatible 3D-printed microneedle array that can comfortably access skin interstitial fluid and a small circuit for signal processing and calibration, and wireless communication. The microneedle array features good biocompatibility and highly sensitive biochemical sensors that can detect even the slightest variations within the biomarkers of this fluid. On-body experimental results indicate that such a sensor can monitor fitness-related biomarkers across multiple subjects and support multi-day monitoring, with results showing a good correlation with commercial devices. The data was transmitted to a smartphone via Bluetooth and uploaded to cloud platforms for further health assessment. This study has the potential to boost intelligent wearable devices in sports health.

Microneedle patch casting using a micromachined carbon master for enhanced drug delivery

For successful treatment of diseases, sufficient therapeutics must be provided to the body. Microneedle applications in therapeutic delivery and analytics sampling are restricted because of various issues, including smaller area for drug loading and analytics sampling. To achieve sufficient drug loading and analytics sampling and improve drug penetration while maintaining painless administration, patch-type microneedle arrays were designed and fabricated using polymer casting from a conical cavity mold. Microcavities were formed on a carbon plate via micromechanical machining. A porous polymer layer was coated on a microneedle patch (MNP). The pores of the porous polymer layer provided space and channels for drug delivery. A pH-sensitive polymer layer was employed to cap the porous polymer layer, which prevented drug leakage during storage and provided a stimulus drug release in response to body pH conditions. The drug can be delivered through holes connected to both sides of the patch. The drug release of the MNP was investigated in vitro and in vivo and showed conceptual proof that these MNs have the potential to enhance treatment protocols for various diseases with the flexibility of coating and therapeutic materials and offer significant scope for further variations and advancement.

Deferasirox nanosuspension loaded dissolving microneedles for ocular drug delivery

Deferasirox (DFS) is an oral iron chelator that is employed in retinal ailments as a neuroprotectant against retinal injury and thus has utility in treating disorders such as excitoneurotoxicity and age-related macular degeneration (AMD). However, the conventional oral route of administration can present several disadvantages, e.g., the need for more frequent dosing and the first-pass effect. Microneedles (MNs) are minimally invasive systems that can be employed for intrascleral drug delivery without pain and can advantageously replace intravitreal injections therapy (IVT) as well as conventional oral routes of delivery for DFS. In this study, DFS was formulated into a nanosuspension (NS) through wet media milling employing PVA as a stabilizer, which was successfully loaded into polymeric dissolving MNs. DFS exhibited a 4-fold increase in solubility in DFS-NS compared to that of pure DFS. Moreover, the DFS-NSs exhibited excellent short-term stability and enhanced thermal stability, as confirmed through thermogravimetric analysis (TGA) studies. The mechanical characterization of the DFS-NS loaded ocular microneedles (DFS-NS-OcMNs), revealed that the system was sufficiently strong for effective scleral penetration. Optical coherence tomography (OCT) images confirmed the insertion of 81.23 ± 7.35 % of the total height of the MN arrays into full-thickness porcine sclera. Scleral deposition studies revealed 64 % drug deposition after just 5 min of insertion from DFS-NS-loaded ocular microneedles (OcMNs), which was almost 5 times greater than the deposition from pure DFS-OcMNs. Furthermore, both DFS and DFS-NS-OcMN exhibited remarkable cell viability when evaluated on human retinal pigment (ARPE) cells, suggesting their safety and appropriateness for use in the human eye. Therefore, loading DFS-NS into novel MN devices is a promising technique for effectively delivering DFS to the posterior segment of the eye in a minimally invasive manner.

Fabrication of Hybrid Coated Microneedles with Donepezil Utilizing Digital Light Processing and Semisolid Extrusion Printing for the Management of Alzheimer's Disease.

Microneedle (MN) patches are gaining increasing attention as a cost-effective technology for delivering drugs directly into the skin. In the present study, two different 3D printing processes were utilized to produce coated MNs, namely, digital light processing (DLP) and semisolid extrusion (SSE). Donepezil (DN), a cholinesterase inhibitor administered for the treatment of Alzheimer's disease, was incorporated into the coating material. Physiochemical characterization of the coated MNs confirmed the successful incorporation of donepezil as well as the stability and suitability of the materials for transdermal delivery. Optical microscopy and SEM studies validated the uniform weight distribution and precise dimensions of the MN arrays, while mechanical testing ensured the MNs' robustness, ensuring efficient skin penetration. In vitro studies were conducted to evaluate the produced transdermal patches, indicating their potential use in clinical treatment. Permeation studies revealed a significant increase in DN permeation compared to plain coating material, affirming the effectiveness of the MNs in enhancing transdermal drug delivery. Confocal laser scanning microscopy (CLSM) elucidated the distribution of the API, within skin layers, demonstrating sustained drug release and transcellular transport pathways. Finally, cell studies were also conducted on NIH3T3 fibroblasts to evaluate the biocompatibility and safety of the printed objects for transdermal applications.

Design of poly(vinyl pyrrolidone) and poly(ethylene glycol) microneedle arrays for delivering glycosaminoglycan, chondroitin sulfate, and hyaluronic acid

Osteoarthritis (OA) is a prevalent joint disorder characterized by cartilage and bone degradation. Medical therapies like glucosaminoglycan (GAG), chondroitin sulfate (CS), and hyaluronic acid (HA) aim to preserve joint function and reduce inflammation but may cause side effects when administered orally or via injection. Microneedle arrays (MNAs) offer a localized drug delivery method that reduces side effects. Thus, this study aims to demonstrate the feasibility of delivering GAG, CS, and HA using microneedles in vitro. An optimal needle geometry is crucial for the successful application of MNA. To address this, here we employ a multi-objective optimization framework using the non-dominated sorting genetic algorithm II (NSGA-II) to determine the ideal MNA design, focusing on preventing needle failure. Then, a three-step fabrication approach is followed to fabricate the MNAs. First, the master (male) molds are fabricated from poly(methyl methacrylate) using mechanical micromachining based on optimized needle geometry. Second, a micro-molding with Polydimethylsiloxane (PDMS) is used for the fabrication of production (female) molds. In the last step, the MNAs were fabricated by microcasting the hydrogels using the production molds. Light microscopy (LIMI) confirms the accuracy of the MNAs manufactured, and in vitro skin insertion tests demonstrate failure-free needle insertion. Subsequently, we confirmed the biocompatibility of MNAs by evaluating their impact on the L929 fibroblast cell line, human chondrocytes, and osteoblasts.

Controlled Transdermal Delivery of Dexamethasone for Pain Management via Photochemically 3D-Printed Bioresorbable Microneedle Arrays.

Microneedle array patches (MAPs) are extensively studied for transdermal drug delivery. Additive manufacturing enables precise control over MAP customization and rapid fabrication. However, the scope of 3D-printable, bioresorbable materials is limited. Dexamethasone (DXM) is widely used to manage inflammation and pain, but its application is limited by systemic side effects. Thus, it is crucial to achieve high local drug concentrations while maintaining low serum levels. Here, poly(propylene fumarate-co-propylene succinate) oligomers are fabricated into DXM-loaded, bioresorbable MAPs via continuous liquid interface production 3D printing. Thiol-ene click chemistry yields MAPs with tailorable mechanical and degradation properties. DXM-loaded MAPs exhibit controlled elution of drug in vitro. Transdermal application of DXM-loaded MAPs in a murine tibial fracture model leads to substantial relief of postoperative pain. Pharmacokinetic analysis shows that MAP administration is able to control pain at a significantly lower dose than intravenous administration. This work expands the material properties of 3D-printed poly(propylene fumarate-co-propylene succinate) copolyesters and their use in drug delivery applications.

Co3O4 Based Non-Enzymatic Microneedle Glucose Sensor for Plant Health Monitoring

Over the last decade, various wearable sensor technologies that can monitor human health precisely in real time have extensively been developed. More recently, such wearable biosensor technologies have been employed to observe the condition of plants as well. In particular, a glucose sensor, which has been actively researched for diabetes, can also be applied to plants. A level of glucose concentration in plants indicates cellular metabolic status, biotic and abiotic stress of plants. However, unlike advanced glucose sensors for humans, early glucose sensors based on glucose oxidase are still used in plants glucose monitoring. The enzyme-based glucose sensor has several disadvantages including the stability problem due to denaturation of enzymes and difficulty of immobilizing enzymes on the electrode surface. Additionally, glucose oxidase needs a redox shuttle to transfer electrons, which complicate the sensor manufacturing process. Moreover, H2O2 is generated as a byproduct of glucose oxidase and glucose reaction, which can cause damage to plants and enzymes.In this study, non-enzymatic microneedle (MN) glucose sensor was developed using Co3O4 as a substitute for glucose oxidase. Co3O4 have electrocatalytic properties and chemical stability, showing higher sensitivity compared to glucose oxidase, and is suitable for long-term monitoring. However, it has the disadvantage of low electrical conductivity, making it difficult to transfer electrons, which are generated from the reaction with glucose, to a sensor electrode. Therefore, carbon nanomaterials were mixed to increase electron transfer efficiency and drop casted on the working electrode of a screen-printed sensor. To optimize the ratio of Co3O4 and carbon nanomaterials, the sensitivity was observed by comparing the peak current of cyclic voltammogram and saturation currents of amperogram according to each mixing ratio. Through the analysis results, it was confirmed that 17 wt% carbon nanomaterial had the highest sensitivity of 207 μA/mM cm2. Afterwards, a MN array sensor was fabricated to measure the glucose in plant leaves. MN can penetrate the epidermis of the leaf and enable to measure the glucose from near the phloem of the leaf. MN array structure was fabricated by dispensing SU-8 into a PDMS negative mold and cured by UV exposure. The working and reference electrode of MN array were coated with Co3O4/carbon composite and pseudo-Ag/AgCl ink, respectively, using a pneumatic 3D printer. Pt sputtering was conducted for forming the counter electrode. The metabolism of plants was confirmed by measuring the glucose concentration of leaves at day and night using a MN glucose sensor.

Transdermal drug delivery of rizatriptan using microneedles array patch: preparation, characterization and ex-vivo/in-vivo study

Given the extensive first pass metabolism of rizatriptan in oral administration and its delayed absorption during a migraine attack as a result of gastric stasis, focus has been on transdermal delivery. The main purpose of this study is to prepare and assess transdermal formulation of rizatriptan, loaded on hydrogel microneedles delivery system, to avoid first pass metabolism and also improve its percutaneous permeation rate. Rizatriptan hydrogel microneedles were prepared using micromolding method and evaluated in terms of mechanical strength, encapsulation efficiency, permeation and in-vivo skin absorption. Different formulations of rizatriptan microneedles (F1–F5) were successfully prepared using different concentrations of carboxymethyl cellulose and gelatin type A. Rizatriptan hydrogel microneedles demonstrated favorable mechanical properties, including withstanding insertion forces, thereby enhancing its skin insertion ability. In permeation study, the percent cumulative drug released after 24 h ranged between 93.1–100% which means that microneedles were able to deliver the drug effectively. For in-vivo study, F3 formulation was selected due to its superior characteristics over other formulations as it exhibited the highest swelling capacity, and demonstrated favorable mechanical properties. Furthermore, F3 showcased the most controlled drug release over a 24-hour period. Relative bioavailability of F3 microneedles was 179.59% compared to oral administration based on the AUC0-24. The observed AUC0-24 in F3 microneedles was statistically significant and 1.80 times greater than that in oral administration. The higher rizatriptan level in the microneedle demonstrated adequate drug permeability through the rat skin, suggesting the potential of microneedles for enhanced therapeutic effectiveness.

Cleanroom-Free Fabrication of Flexible Microneedle Array Patches for Minimally Invasive Monitoring of Dopamine

Cleanroom-Free Fabrication of Flexible Microneedle Array Patches for Minimally Invasive Monitoring of Dopamine

Application of MOF Nanoenzyme in Rapid Detection of Food Allergens System

Food allergies are a common immune response that can lead to serious health problems. Rapid and accurate detection of allergens in food is crucial for protecting people’s health and quality of life. In this study, β-lactoglobulin in milk serves as a model allergen, and nucleic acid aptamer-loaded MN patches are utilized as rapid capture elements. Moreover, metal organic frameworks loaded with complementary aptamer sequences are employed as signal amplification elements. The combination of these two elements establishes a rapid visualization detection system for allergens, employing specific microneedle array patches-MOF nanoenzymes. The results show that the combination of TMB+H2O2 +MOF-RC has the highest peroxidase like activity of 1.732. Compared to TMB+H2O2 +MOF, it has increased by 0.547. Meanwhile, the MN-MOF detection method has excellent specificity for the detection of β-Lg. This specific microneedle array patches and MOF nanoenzymes-based allergen rapid detection system demonstrates practical application benefits, providing a viable solution for swiftly detecting food allergens and safeguarding people’s health and quality of life.